Blog
-
-
Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data
-
Drug Could Be a ‘Game-Changer’ in Fighting Esophageal Cancers
-
5 FDA approval decisions to watch in the second quarter
-
World-first discovery paves way to new cancer treatment
-
FDA Approves First in the World Device to Treat Patients with Congenital Heart Disease
-
Drug Boosts Survival for Women With Advanced Ovarian Cancer
-
FDA Clears Boston Scientific TheraSphere Y-90 Transcatheter Liver Embolization Microspheres
-
ECRI says COVID-19 has made racial disparities biggest healthcare safety concern
-
When employers adopt bundled payments, surgical costs can drop by 11%, study finds